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ABSTRACT: A detailed review on Guggulu, covering its botanical, Chemical Pharmacological 
and Ayurvedic aspects, is presented here. 
 
Guggulu is an oleogum resin (Oleoresin) 
that exudes spontaneously as a result of 
injury from the bark of Commiphora wightii 
Bhandari (Syn : Commiphora mukul Hook. 
ex Stocks or Balsamodendron mukul Hook. 
ex Stocks) which is a weird tree of the arid 
zones of Central India and Deccan Plateau. 
 
This tree belongs to the family Burseraceae 
and is exceedingly sluggish in growth, 
crooked, twiggy and thorny reaching 3 
metres in height and practically lacking 
foliage except during the moist season (Fig. 
1).  But the trunk and the branches are 
always of a grey metallic sheen with 
horizontally peeling off papery cork.  The 
flowers are minute amidst the few serrate 1 
to 3 foliate leaves that are rarely exceeding 2 
cms across and along. 
 
The local people who collect the gum resin 
make incisions on the trunk and major 
branches during February –  April period.  
The gum slowly exudes and gradually 
hardens in tears and frequently drips on the 
ground.  The process is complete in a week 
or so.  Then fresh gashes have to be inflicted 
to further bleed the tree.  It has been noted 
that several trees are killed every year by 
avaricious hacking.  As a result the 
commodity is progressively dwindling in 
supply leading to ingenious adulteration by 
admixture with other gums obtained from 
wild trees like Karaya (Sterculia urens 
Roxb.) and Moringa (Moringa oledifera 
Lam.) 
 
The freshly exuded gum is syrupy and is 
golden yellow in colour.  In the due course it 
hardens and becomes yellowish blue green 
but remains sticky.  This colour is aptly 
described by the synonymn ‘Mahisaksi’ 
which in Sanskrit means, ‘baffalo eye’.   
Guggulu is a mixture of gum, resin and 
essential oil and hence it is better termed 
‘Oleogum – resin’. 
 
Chemical Studies 
 
A detailed chemical study of guggulu 
revealed that it is a complex mixture of 
steroids, diterpenoids, aliphatic esters, 
carbohydrates, amino acids and variety of 
inorganic compounds.  Besides known 
sesamin and cholesterol, Sukh Dev et al 
have isolated Z –  guggulsterone, E- 
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and three new sterols viz. guggulsterols I, II 
& III (1) Fig. (2). 
 
Later workers have isolated two more new 
sterols guggulsterol – IV and guggulsterol – 
V (2) (Fig. 3). 
 
Besides a new alcohol viz. mukulol (3), four 
steroids too have been isolated from guggulu 
(4). (Fig. 4). 
 
General Pharmacology 
 
The oleogum resin has been put to medicinal 
use in Ayurveda for a variety of ailments as 
shown by its being specifically spoken of by 
Caraka and Susruta in their treatises.   
According to them the drug is useful in the 
following conditions, viz. heart diseases, 
obesity, tumours, urinary infections and 
calculi, ascites, piles, fistula, worms, skin 
diseases, vitiligo, arthritis and rheumatism, 
swellings, malignant ulcers, and pains.   
However, guggulu is currently reported for 
its efficacy as an excellent antiarthritic, 
antirehumatic, antiphlogistic and 
hypolipaemic.  When a plethora of synthetic 
drugs are in current use for these ailments 
the extensive employment of guggulu by the 
indigenous as well as modern medical 
practitioners confirms the utility of the drug 
particularly in combating corpulence. 
 
Anti – inflammatory Activity 
 
Pharmacological studies have shown that the 
oleoresin is a highly potent anti 
inflammatory agent as compared to 
hydrocortisone and butazolidin against 
Brownlee’s formaldehyde induced arthritis 
in albino rats (5).  The acidic fraction of the 
oleo resin was active one whereas the non – 
acidic and the solid fractions were inactive.  
The activity of the acidic portion was 
present even in the adrenalectomised 
animals (6). 
 
The steroidal fraction from the petroleum 
ether extract of the guggulu showed 
significant effect on the primary as well as 
the secondary inflammation induced by 
Freund’s adjuvant.  It was more effective 
than hydrocortisone in reducing the severity 
of secondary lesions.  Its antiphlogistic 
effect was comparable to that of 
hydrocotisoneacetate (7). 
 
The aqueous extract of guggulu suppressed 
acute rat paw oedema induced by 
carragenin.  It was active in granuloma 
pouch test also.  In adjuvant arthritis this 
extract suppressed the secondary lesions 
very effectively without having any 
significant action on the Primary Phase.   
Side effects such as gastric ulceration, loss 
of weight and mortality were negligible in 
animals treated with betamethasone (8). 
 
In Freund’s adjuvant arthritis the lipid 
extract (250 mg/kg) produced activity 
comparable to pheylbutazone.  However, in 
the dosage used it caused significant 
morbidity and mortality (9).  Petroleum 
ether extract showed significant inhibition of 
joint swelling in experimental rabbits.   
Fraction – A of gum guggulu showed anti – 
inflammatory activity in human beings at a 
dose level of 500 mg / kg / day (10). Pages 104 - 112 
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The fraction – A of guggulu was compared 
with phenylbutazone and brufen (11) and the 
whole drug with a nonsteroidal anti – 
inflammatory agent indomethacin and a 
steroidal drug dexamethazone (12).  It was 
found that guggulu has clinically 
demonstrable anti – inflammatory activity. 
 
Anti – arthritic Activity. 
 
Suddha guggulu administered to 30 patients 
of rheumatoid arthritis showed complete 
remission (66.66%) major to minor (23.33% 
-  10%) improvement besides anti – 
inflammatory and analgesic properties (13).  
Composite drugs with Simhanada guggulu 
(14) and Vyosadi guggulu (15) were also 
found to be effective in the treatment of 
rheumatoid arthritis. 
 
Guggulu in combination with septalin is 
more effective and has no side effects (16).  
In combination with Nirgundi (Vitex 
negundo)  it was found to be useful in 
sciatica (17); with Bhallataka (Semecarpus 
anacandium)  and  Gowrakh (Dalbergia 
lanceolaria) it was effective in the treatment 
of osteoarthritis and sciatica (18). 
 
Hypochloesterolemic Activity 
 
Crude guggulu was found to possess highly 
encouraging hypolipaemic activity in rabbits 
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the serum cholesterol in 
hypercholesterolemic rabbits but also 
protected the animals against 
hypercholesterolemia induced by 
hydrogenated vegetable oil and cholesterol.  
It was useful also in cholesterol induced 
antherosclerosis.  It reduced the body weight 
of the experimental animals (20). 
 
Crude guggulu and its alcohol soluble 
fractions caused significant fall in serum 
cholesterol and serum turbidity with a 
concomitant increase in the coagulation time 
and prothrombin time (21, 22).  In Indian 
domestic pigs the alcohol extract lowered 
serum  cholesterol,  β  –  lipoprotein and its 
cholesterol content and significantly altered 
the α – β lipoprotein ration (23). 
 
Studies carried out on monkeys fed on 
cholesterol diet indicated that fraction – A of 
the petroleum ether extracts could 
effectively lower serum total  lipids, 
cholesterol, phospholipids and triglyceries.   
The hypolipaemic activity in this case was 
comparable to that of Atromid – S (24). 
 
Fraction A and a steroidal fraction present in 
guggulu also showed significant 
hypolipaemic activity in cholesterol fed 
chicks (25, 26).  Alcoholic extract and a 
pure steroid isolated from it reduced serum 
cholesterol level in normal and triton 
induced hyperlipidemic rats and cholesterol 
fed hyperlipidemic rabbits (27). 
 
Clinical studies on patients of 
hypercholesterolemia associated with 
obesity, ischaemic heart diseases, 
hypertension, diabetes, etc. showed a fall in 
total serum cholesterol and serum 
lipiphosphorous when treated with guggulu.  
The body weight of the obese ones declined 
significantly (28).  Other clinical  studies 
showed that the lowering of serum 
triglucerides was found most encouraging in 
case of gum guggulu in comparison to all 
the drugs known so far (29). 
 
In a long term clinical study it was found 
that fraction A of guggulu in cases of 
hyperlipoproteinaemia reduced triglycerides 
by 36.5% whereas the drug clofibrate 
brought a reduction of 33.3%.  Serum 
cholesterol was reduced by 26.2% with 
fraction – A treatment when 31.5% was the 
result with clofibrate.  Fraction –  A 
enhanced the rate of excretion of cholesterol 
and also reduced its synthesis (30). 
 
Spontaneous hypercholesterolemia and 
hyperglyceridemia were induced in male 
gerbils with stock diet alone.  Fraction A 
showed maximum activity after 24 weeks.   
But the activity against atherosclerosis could 
not be studied as no spontaneous 
atherosclerosis was developed during the 
period of 48 weeks (31). 
 
A ketosteroid (C21H30O3) from the gum was 
studied against endogeneous 
hypercholesterolemia and hyperlipidemia 
induced by oral administration of 
neomercazole and cholesterol in chicks.  In 
this study neomercazole induced thyroid cell 
proliferation was prevented by the 
ketosteroid.  This showed that the drug 
influences the lipid metabolism by 
activating the thyroid. 
 
Gupta et al (23) studied the effect of fraction 
A on the estrogen induced hyperlipidemia in 
white leghorn male chicks.  The drug 
showed effective hypolipidemic activity in 2 
weeks and it also antagonized the 
hypertrophy of the liver and showed 
thyrogenic activity. 
 
A systematic double blind clinical trial on 
40 obsese patients was carried out with 
crude guggulu and its petroleum ether 
fraction A.  Serum cholesterol was Pages 104 - 112 
 
 
significantly reduced without affecting the 
body weight (34).  Similar studies were done 
by Kotiyal et al (35) and Baldwa et al (36).  
The latter team found that the hypolipidemic 
activity was more than that of garlic (37). 
 
In the treatment of coronary –  heart 
diseases 
 
The fraction A and the steroidal component 
derived from it were studied in experimental 
myocardial infarction in rats produced by 
isoprenaline.  The results show that guggulu 
is one of a few drugs which is effective in 
both hyperlipidemia and myocardial 
necrosis (38). 
 
The effect of the gum guggulu on serum 
cholesterol, fibrinolytic activity and platelet 
adhesive index in  healthy patients and in 
patients of coronary artery disease was 
studied.  The fibrinolytic activity increased 
(40% and 30%) while platelet adhesive 
index showed fall (19% and 16%) at the end 
of 15 days (39). 
 
Purified steroidal fraction of guggulu 
showed  a marked inhibition of ADP, 
adrenaline and serotonin induced platelet 
aggregation.  Their inhibiting effect was 
comparable to that of clofibrate (40).  Later 
investigations also confirmed this activity of 
the drug (41). 
 
Upadhyaya et al (42) studied the effect of 
guggulu on patients with coronary 
insufficiency and obesity.  At the end of 
three months the drug showed 27.8% 
reduction in serum cholesterol and 32.7% 
reduction of serum triglyceride.  Subjective 
improvement had been observed in 
precordial pain and dysponea and the T 
wave had been corrected. 
 
Clinical trials have shown that the drug is 
useful in the management of hemiplegia 
which is also an atherosclerotic disorder 
(43). 
 
Anti – fertility activity 
 
Guggulu caused a reduction in the weight of 
rat uterus, ovaries and cervix with a 
concomitant increase in their glycogen and 
sialic acid levels thereby showing that it 
might be useful as an antifertility agent (44). 
 
Analgesic activity 
 
Myostal, a composite drug containing 
guggulu, Simhanada guggulu, abhraka 
bhasma, Vaca, Rasna, Goksura, Sankha 
bhasma was tried in 50 puerperal 
primiparous patients.  The drug was 
effective in reducing pain during puerperium 
without affecting involution in mother or 
physiology of the new born (45). 
 
In infective hepatitis 
 
Biliarin, a compound drug containing 
guggulu, triphala, katuki, punarnava, 
mandua (reduced iron) and nux vomica was 
tried in 50 cases of liver disorders in 
children.  The drug showed good effects in 
infective hepatitis (46).  Earlier the 
antagonizing property of guggulu on the 
liver hypertrophy has been established (33). 
 
Aphrodisiac activity 
 
Because of ushna  –  teekshna  properties, 
guggulu stimulates sexual ardour; acts as 
emmanogogue.  Being snigddha – picchila it 
acts as an aphrodisiac (47). 
 
Thyrogenic activity 
 
In  vitro  studies on thyrogenic effect of 
guggulu on mice suggested that the drug 
may be used for the management of 
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disorders like hypercholesterolaemia, 
hyperlipidaemia and atherosclerosis (48). 
 
Uses in Ayurveda 
 
In Ayurvedam guggulu enters into the 
preparation of several compound medicines 
most of which are named with suffix 
‘guggulu’ (Table – I). 
 
The verse 44 of chapter V of Cikitsasthana 
of Susruta Samhita details the areas for 
intensive studies.  It runs thus: Guggulu is 
light, aromatic, penetrating into the minutes 
parts of the body, sharp, warmth generating 
in potency, pungent in taste and digestion, 
laxative, lubricating and whole some to the 
heart.  New (fresh) guggulu is an 
aphrodisiac and anabolic.  Old guggulu is 
anti-fat and reduces corpulency.  Due to 
sharpness and warming nature it reduces 
Vayu  and  Kapha.  Because of its laxative 
nature it flushes out the waste products from 
all tissues and systems.  Its aroma removes 
bad odours.  Its subtle essence awakens the 
appetizing factors. 
 
Methods of administration according to 
Ayurveda 
 
Guggulu should be taken in the mornings 
with Triphala decoction, Berberies 
decoction, bitter-gourd diction or cow’s 
urine, warm milk and water.  The person 
should take boiled rice with milk, soup or 
meat extract after some time.  Diseases such 
an internal tumours, urinary tract ailments, 
ascites, piles, fistula, helminthasis, skin 
diseases, aversion to food, vitiligo, sinus, 
pains, swellings, malignant ulcers and sores 
reliably yield to it, if used for a month.  It 
destroys deranged vata from the tissues and 
systems, bones and joints just as a thunder 
bolt destroys trees. 
 
In the treatment with guggulu no acute or 
chronic toxicity was found (26).  Mild 
gastrointestinal upsets may be present in 
some cases (34).  Microscopic examination 
of the liver, kidney and heart of the chicks 
treated with guggulu indicated no toxic 
effects.  Kidney irritation, abdominal 
discomforts and pruritus with slight oedema 
had been reported 937).  But it is quite 
harmless and can be taken for a long time 
(49). 
 
Conclusion 
 
While recent researchers have focused 
attention on the anti-inflammatory activity 
and hypolipaemic activity of guggulu 
comparatively less work has been done 
relating to other properties of the drug 
enumerated in Ayurveda.  Pharmacological 
and clinical studies to evaluate the efficacy 
of the drug in conditions mentioned in 
Ayurvedic texts with references to its 
particular modes of actions will open up 
avenues of its being put to better and even 
newer applications. 
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